X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with PLETHICO PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs PLETHICO PHARMA - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER PLETHICO PHARMA PFIZER/
PLETHICO PHARMA
 
P/E (TTM) x 28.8 -1.1 - View Chart
P/BV x 4.6 0.0 27,290.1% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 PFIZER   PLETHICO PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-16
PLETHICO PHARMA
Mar-14
PFIZER/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs2,724395 689.8%   
Low Rs1,61131 5,147.0%   
Sales per share (Unadj.) Rs440.9604.4 72.9%  
Earnings per share (Unadj.) Rs48.732.5 149.9%  
Cash flow per share (Unadj.) Rs75.851.3 147.6%  
Dividends per share (Unadj.) Rs15.000-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs462.9473.6 97.8%  
Shares outstanding (eoy) m45.7534.08 134.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.90.4 1,394.4%   
Avg P/E ratio x44.56.6 678.4%  
P/CF ratio (eoy) x28.64.2 689.0%  
Price / Book Value ratio x4.70.5 1,040.4%  
Dividend payout %30.80-   
Avg Mkt Cap Rs m99,1637,262 1,365.4%   
No. of employees `0002.9NA-   
Total wages/salary Rs m2,7581,596 172.8%   
Avg. sales/employee Rs Th6,981.7NM-  
Avg. wages/employee Rs Th954.5NM-  
Avg. net profit/employee Rs Th771.1NM-  
INCOME DATA
Net Sales Rs m20,17020,598 97.9%  
Other income Rs m857386 221.9%   
Total revenues Rs m21,02820,984 100.2%   
Gross profit Rs m4,3102,818 153.0%  
Depreciation Rs m1,239642 192.9%   
Interest Rs m51,593 0.3%   
Profit before tax Rs m3,923969 405.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,794-138 -1,296.7%   
Profit after tax Rs m2,2281,107 201.3%  
Gross profit margin %21.413.7 156.2%  
Effective tax rate %45.7-14.3 -320.1%   
Net profit margin %11.05.4 205.5%  
BALANCE SHEET DATA
Current assets Rs m16,29918,877 86.3%   
Current liabilities Rs m7,59411,896 63.8%   
Net working cap to sales %43.233.9 127.3%  
Current ratio x2.11.6 135.3%  
Inventory Days Days6536 181.6%  
Debtors Days Days26198 13.0%  
Net fixed assets Rs m8,6229,861 87.4%   
Share capital Rs m458341 134.3%   
"Free" reserves Rs m20,72212,331 168.1%   
Net worth Rs m21,18016,139 131.2%   
Long term debt Rs m254,706 0.5%   
Total assets Rs m29,13733,146 87.9%  
Interest coverage x755.51.6 46,985.7%   
Debt to equity ratio x00.3 0.4%  
Sales to assets ratio x0.70.6 111.4%   
Return on assets %7.78.1 94.1%  
Return on equity %10.56.9 153.4%  
Return on capital %19.012.3 154.5%  
Exports to sales %0.121.4 0.3%   
Imports to sales %17.515.2 114.8%   
Exports (fob) Rs m124,402 0.3%   
Imports (cif) Rs m3,5263,136 112.4%   
Fx inflow Rs m524,402 1.2%   
Fx outflow Rs m1403,184 4.4%   
Net fx Rs m-881,219 -7.2%   
CASH FLOW
From Operations Rs m3,4362,437 141.0%  
From Investments Rs m-6,991-6,265 111.6%  
From Financial Activity Rs m-6192,490 -24.9%  
Net Cashflow Rs m-4,174-1,337 312.1%  

Share Holding

Indian Promoters % 0.0 82.7 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 4.3 174.4%  
FIIs % 4.9 5.5 89.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 7.5 316.0%  
Shareholders   85,207 10,665 798.9%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   WOCKHARDT LTD.  J.B.CHEMICALS  ORCHID PHARMA LTD  BIOCON LTD  FULFORD INDIA  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Jan 19, 2018 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS